T. Rowe Price Associates’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,500	Closed	-$152K	–	3055
2024 Q1	$152K	Sell	1,500 -500	-25%	-$50.7K	﹤0.01%	2692
2023 Q4	$48K	Hold	2,000	–	–	﹤0.01%	2810
2023 Q3	$42K	Buy	+2,000	New	+$42K	﹤0.01%	2790